跳至主要内容
临床试验/NCT05372510
NCT05372510Unknown不适用

A Pilot Study to Evaluate the Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

MRC/UVRI and LSHTM Uganda Research Unit1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年2月17日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
To measure the number of individuals who are Genexpert HIV Viral load assay positive and Alere Determine HIV-1/2 Negative.

研究概览

简要总结

It is only between peak viremia and viral setpoint in natural acute HIV-1 infection that the immune response overwhelms viral replication resulting in a plasma viral load decline. The aim will be to characterize these immune responses, how they develop and their progeny. This will require the need to identify HIV-1 infected individuals before peak viremia and follow them to post viral setpoint.

This protocol describes a pilot study to evaluate the feasibility of identifying, enrolling and following acute and early HIV-1 infected individuals from voluntary counselling and testing centres in Masaka, Bukomansimbi, Kalungu, Lwengo, Sembababule and Lyantonde districts.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Females and males.
  • Able and willing to provide informed consent.
  • Willing to undergo HIV testing using GeneX pert Viral Load assay.
  • Able and willing to provide accurate locator information for tracking purposes and willing to be contacted by study staff.
  • Willing to complete interviewer administered questionnaires on risk factors and if infected, questions related to the route and timing of exposure.

排除标准

  • Has any condition that in the opinion of the principal investigator or designee, would preclude provision of informed consent, or otherwise interfere with achieving the study objectives.
  • Participation in a current clinical trial unless approved by the investigators and IAVI medical monitor.

结局指标

主要结局

To measure the number of individuals who are Genexpert HIV Viral load assay positive and Alere Determine HIV-1/2 Negative.

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
MRC/UVRI and LSHTM Uganda Research Unit
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Andrew Obuku

SCIENTIST

MRC/UVRI and LSHTM Uganda Research Unit

研究点 (1)

Loading locations...

相似试验